We incorporated a metabolic model alongside proteomics measurements, aiming to quantify the uncertainty in a range of pathway targets in order to improve the production of isopropanol. Computational methods, including in silico thermodynamic optimization, minimal protein requirement analysis, and ensemble modeling robustness analysis, highlighted acetoacetyl-coenzyme A (CoA) transferase (AACT) and acetoacetate decarboxylase (AADC) as the top two significant flux control points. Consequently, increased isopropanol production is anticipated through overexpression of these points. Our predictions were instrumental in driving the iterative construction of pathways, thereby achieving a 28-fold enhancement in isopropanol production over the initial design. The engineered strain underwent further evaluation in a gas-fermenting mixotrophic setting. CO, CO2, and fructose as substrates led to an isopropanol yield greater than 4 grams per liter. In a bioreactor environment, sparging with CO, CO2, and H2 gases, the strain resulted in an isopropanol concentration of 24 grams per liter. Gas-fermenting chassis, as demonstrated in our work, can be fine-tuned for optimized bioproduction by skillfully and intricately engineering their metabolic pathways. Gaseous substrates, exemplified by hydrogen and carbon oxides, will require a systematic optimization of the host microbes for highly efficient bioproduction. The rational reconstruction of gas-fermenting bacterial metabolic pathways is still in its rudimentary phase, constrained by the lack of precise quantitative metabolic data which would be instrumental in directing strain engineering. A case study regarding the engineering of isopropanol synthesis process in the gas-fermenting Clostridium ljungdahlii organism is provided. We demonstrate the capability of a pathway-level thermodynamic and kinetic modeling approach to deliver actionable insights that guide optimal bioproduction strain engineering. This approach may offer a means to achieve iterative microbe redesign, which may be applied for the conversion of renewable gaseous feedstocks.
The severe threat to human health posed by carbapenem-resistant Klebsiella pneumoniae (CRKP) is largely attributable to the spread of a few dominant lineages, each defined by specific sequence types (STs) and capsular (KL) types. One such dominant lineage, ST11-KL64, boasts a widespread distribution, including a high prevalence in China. Uncovering the population structure and the geographical origin of the ST11-KL64 K. pneumoniae strain is still an open question. All K. pneumoniae genomes, totaling 13625 (as of June 2022), were sourced from NCBI, encompassing 730 ST11-KL64 strains. Through phylogenomic analysis of the core genome, marked by single-nucleotide polymorphisms, two prominent clades (I and II) emerged, in addition to an isolated strain ST11-KL64. Ancestral reconstruction analysis, employing BactDating, revealed clade I's likely emergence in Brazil during 1989, and clade II's emergence in eastern China around 2008. We then investigated the genesis of the two clades and the sole representative using a phylogenomic approach, along with the study of potential sites of recombination. We hypothesize that the ST11-KL64 clade I lineage arose from hybridization, with a calculated 912% (approximately) proportion of the genetic material stemming from a different source. The ST11-KL15 lineage is responsible for 498Mb (88%) of the chromosome's composition, with 483kb originating from the ST147-KL64 lineage. Conversely, the ST11-KL64 clade II lineage originated from ST11-KL47, marked by the exchange of a 157-kilobase segment (representing 3 percent of the chromosome) housing the capsule gene cluster with the clonal complex 1764 (CC1764)-KL64 strain. The singleton, having roots in ST11-KL47, also underwent modification through the replacement of a 126-kb region with the ST11-KL64 clade I. In retrospect, the ST11-KL64 lineage displays a heterogeneous composition, encompassing two major clades and a single, unique strain, arising from different countries and different periods. Globally, carbapenem-resistant Klebsiella pneumoniae (CRKP) presents a serious threat, extending hospital stays and significantly increasing mortality among afflicted individuals. CRKP's dissemination is significantly influenced by a small number of dominant lineages, including ST11-KL64, which is prevalent in China and has a global presence. Through a genomic analysis, we explored the hypothesis that ST11-KL64 K. pneumoniae represents a unified genomic lineage. Our investigation into ST11-KL64 indicated a singleton lineage coupled with two major clades that originated in diverse nations and different years. The KL64 capsule gene cluster's acquisition by the two clades and the singleton is traceable to diverse sources, reflecting their separate evolutionary histories. ATX968 Within the K. pneumoniae bacterium, our study indicates that recombination is highly concentrated in the chromosomal region containing the capsule gene cluster. Employing a major evolutionary mechanism, some bacteria rapidly evolve novel clades, providing them with the necessary adaptations for stress-related survival.
Streptococcus pneumoniae's capacity to generate a wide range of antigenically distinct capsule types presents a considerable obstacle to the success of vaccines designed to target the pneumococcal polysaccharide (PS) capsule. In spite of extensive research, many types of pneumococcal capsules remain unknown and/or not fully characterized. Past studies examining pneumococcal capsule synthesis (cps) loci revealed the potential for diverse capsule subtypes within strains categorized as serotype 36 through conventional typing methods. These subtypes, 36A and 36B, were found to represent two pneumococcal capsule serotypes that, while antigenically comparable, are also distinguishable. Analysis of the capsule's PS components in both specimens demonstrates a common repeat unit backbone, [5),d-Galf-(11)-d-Rib-ol-(5P6),d-ManpNAc-(14),d-Glcp-(1], which is further elaborated by two branching structures. Ribitol is the destination of the -d-Galp branch in both serotypes. ATX968 Serotypes 36A and 36B exhibit variations in their structures, specifically the presence of a -d-Glcp-(13),d-ManpNAc branch in 36A and a -d-Galp-(13),d-ManpNAc branch in 36B. Comparing the serogroup 9 and 36 cps loci, which are phylogenetically distant, and all of which specify this specific glycosidic bond, indicated that the presence of Glcp (in types 9N and 36A) contrasted with Galp (in types 9A, 9V, 9L, and 36B) is associated with the identity of four amino acids in the encoded glycosyltransferase WcjA, located within the cps locus. Characterizing the functional underpinnings of enzymes produced by the cps-encoded genes, and their effects on the structure of the capsular polysaccharide, is paramount for refining sequencing-based capsule typing methodologies, and discovering novel capsule variations that remain elusive through traditional serological methods.
The outer membrane of Gram-negative bacteria receives lipoproteins through the action of the localization (Lol) system. Models of lipoprotein transfer by Lol proteins across the inner and outer membranes in Escherichia coli have been extensively characterized, but lipoprotein synthesis and export pathways in numerous bacterial species exhibit significant variations from the E. coli model. Helicobacter pylori, a bacterium found in the human stomach, lacks a homolog of the E. coli outer membrane protein LolB; the E. coli proteins LolC and LolE are equivalent to a single inner membrane protein, LolF; and a homolog of the E. coli cytoplasmic ATPase LolD has not been discovered. This study aimed to locate a protein akin to LolD within the H. pylori bacterium. ATX968 Affinity purification, coupled with mass spectrometry, was employed to discover interaction partners for the H. pylori ATP-binding cassette (ABC) family permease LolF. The identification of the ABC family ATP-binding protein HP0179 as an interaction partner was a key outcome. By engineering conditional expression of HP0179 in H. pylori, we found HP0179's conserved ATP-binding and hydrolysis motifs to be essential components for H. pylori's proliferation. Following affinity purification-mass spectrometry, using HP0179 as bait, LolF was identified as an interaction partner. These observations suggest H. pylori HP0179 as a protein similar to LolD, providing a more nuanced perspective on lipoprotein positioning within H. pylori, a bacterium whose Lol system demonstrates divergence from the E. coli model. Lipoproteins are fundamental to the operation of Gram-negative bacteria, crucial for the organization of LPS molecules on the cell surface, for the integration of proteins into the outer membrane, and for the identification of stress signals within the envelope structure. Lipoproteins play a role in the mechanisms by which bacteria cause disease. Localization of lipoproteins to the Gram-negative outer membrane is often crucial for many of these functions. Lipoproteins are conveyed to the outer membrane by the Lol sorting pathway. Extensive analyses of the Lol pathway have been conducted in the model organism Escherichia coli, yet numerous bacteria utilize alternative components or lack indispensable elements found in the E. coli Lol pathway. A LolD-like protein's identification in Helicobacter pylori provides crucial insights into the workings of the Lol pathway, impacting many bacterial groups. The focus on lipoprotein localization becomes critical for antimicrobial development strategies.
Recent advancements in the study of the human microbiome have highlighted the presence of substantial oral microbes in the stools of individuals experiencing dysbiosis. Despite this, the precise nature of the potential interactions between these invasive oral microorganisms, the commensal intestinal microbiota, and the host organism remain a subject of ongoing investigation. This study, a proof-of-concept, proposed a new model of oral-to-gut invasion by integrating an in vitro model of the human colon (M-ARCOL) representing its physicochemical and microbial profiles (lumen and mucus-associated microbes), a salivary enrichment protocol, and whole-metagenome shotgun sequencing. An in vitro colon model, harboring a fecal sample from a healthy adult volunteer, underwent the injection of enriched saliva from the same individual, mimicking the oral invasion of the intestinal microbiota.